Polymac Thermof. (537573)

Turnaround

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹41.02
Market Cap₹20.01 Cr
P/E Ratio0
ROCE1.97%
ROE—%
Dividend Yield0%
Profit Growth-67.31%
Debt/Equity
Sales Growth14.73%
52-Week Range₹11.74 — ₹41.02
SectorIndustrial Products

Strengths

Concerns

AI Analysis

Let me look at Polymac Thermof through the lens I have used for decades: what does a business earn on the capital it employs, and can I buy it at a price that gives me a margin of safety? Here the answers are uncomfortable. The company has sales growth of 14.73%, and the latest quarter shows ₹4 crore of revenue, but net profit is essentially zero. More importantly, ROCE is only 1.97%. As Benjamin Graham would say, a company that earns nearly nothing on its capital cannot be an investment; it is a speculation. Profit growth is down 67.31%, and the Piotroski F-Score is just 4 out of 9, suggesting weak financial health. There is no dividend, no book value data, no promoter holding disclosure. The stock trades at ₹41.02, exactly the top of its 52-week range of ₹11.74 to ₹41.02, meaning the market has already re-rated this microcap by more than 200% despite deteriorating profits. With a market cap of only ₹20 crore, this is a very small company. I cannot calculate a P/E with any meaning because earnings are near zero; the P/E is quoted as 0.00 only because the denominator has collapsed. In anything like this, I insist on a clear track record of profitability, conservative debt, and a demonstrable moat. I see none of those here. The sales growth is helpful, but growth without earnings is not value creation. At ₹41, the market is paying for a story. I would rather wait until the company proves it can turn revenue into sustainable profit and earn a respectable return on capital. Until then, this is a pass for me.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer